XLRN
Acceleron Pharma Inc.
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
62 hedge funds and large institutions have $527M invested in Acceleron Pharma Inc. in 2013 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
62
Holders Change
+54
Holders Change %
+675%
% of All Funds
1.8%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.09%
New
58
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$83.9M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$71.4M |
| 3 |
DVC
3
Deer VII & Co
Larchmont,
New York
|
$39.4M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$30.3M |
| 5 |
5
Franklin Resources
San Mateo,
California
|
$23.6M |
